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ADP-ribosylation is a reversible and covalent post-translational modiﬁcation in
which the attachment of ADP-ribose is catalyzed by ADP-ribosyltransferases
and the removal of ADP-ribose is catalyzed by ADP-ribosylhydrolases. ADP-
ribosylhydrolase 3 from mouse, consisting of 347 amino-acid residues, has been
cloned, puriﬁed and crystallized. The three-dimensional structure has been
resolved at a resolution of 1.8 A ˚ . The structure constitutes a compact all-
 -helical protein with two Mg
2+ ions located in the active-site crevice. A
structural comparison of mouse ADP-ribosylhydrolase 3 with its human
orthologue shows a high degree of structural similarity. Furthermore, four
prokaryotic proteins deposited in the PDB could be identiﬁed as being
structurally related.
1. Introduction
The addition of ADP-ribose onto proteins is a reversible post-
translational modiﬁcation that is catalysed by a variety of enzymes
(Shall, 1995). It can occur either in the form of mono-ADP-ribosyl-
ation (Seman et al., 2004) or in the form of poly-ADP-ribosylation
(Hassa et al., 2006). ADP-ribosylation is the reaction in which the
ADP-ribose moiety of NAD is transferred to a speciﬁc acceptor
amino-acid residue such as Arg, Asn, Glu, Asp, Cys, diphthamide or
phosphoserine. During the stereospeciﬁc chemical reaction, the
target performs a nucleophilic attack on the anomeric C atom of the
ribose moiety adjacent to nicotinamide in NAD, thereby generating a
covalent linkage with ADP-ribose and releasing nicotinamide. The
hydrolysis of NAD itself can be described as a transfer of ADP-ribose
onto a water molecule.
Many of the bacterial mono-ADP-ribosyltransferases (mARTs)
are known for their toxicity. Prominent examples are diphtheria
toxin, cholera toxin, Salmonella virulence factor SpvB and many
others (Aktories & Just, 2000). ADP-ribosylating toxins catalyse the
transfer of the ADP-ribose moiety from NAD to speciﬁc target
proteins, in many cases GTP-binding or ATP-binding proteins. ADP-
ribosylation often alters the function of the target protein and
disrupts cellular metabolism. SpvB-related mammalian ecto-mARTs
occur as glycosylphosphatidylinositol-anchored or secretory proteins
that can be divided into ﬁve paralogues: mART1–5 (Glowacki et al.,
2002; Seman et al., 2004). Diphtheria-toxin-related poly-ADP-ribosyl-
transferases or poly-(ADP-ribose) polymerases (pARTs or PARPs)
are intracellular, usually nuclear, proteins of eukaryotes (Otto et al.,
2005; Schreiber et al., 2006) that play a role in DNA repair (Malanga
& Althaus, 2005), transcriptional activation and repression (Kim et
al., 2004), chromatin insulation (Yu et al., 2004), cell death (Jagtap &
Szabo, 2005), regulation of mitosis (Chang et al., 2004) or the regu-
lation of telomere length (Smith et al., 1998). It has been suggested
that some members ofthe mARTand PARP families can act both as a
mARTand as a PARP (Otto et al., 2005; Hassa et al., 2006; Morrison
et al., 2006). Additionally, there is evidence for intracellular ADP-
ribosylation, which may be catalyzed by certain members of the
structurally distinct sirtuin family. For instance, SIRT4 has been
shown to regulate insulin secretion by mono-ADP-ribosylating
glutamate dehydrogenase (Haigis et al., 2006; Ahuja et al., 2007).
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All rights reservedThe extent and duration of mono-ADP-ribosylation depends on
the activity of ADP-ribosylhydrolases (ARHs) and poly-ADP-
ribosylglycohydrolases (PARGs), which reverse the transfer reaction
by hydrolysing the protein–ADP-ribose bond and/or ADP-ribose–
ADP-ribose bonds (Koch-Nolte & Haag, 1997; Moss et al., 1997). In
this context, mARTs/PARPs and ARHs/PARGs form opposite pairs
in the ADP-ribosylation reaction cycle (Fig. 1). To date, three
mammalian ARHs (ARH1–3) have been described (Glowacki et al.,
2002), where ARH1 has been reported to cleave ADP-ribosyl-
arginine (Moss et al., 1997) and ARH3 to de-ADP-ribosylate poly-
ADP-ribosylated proteins (Oka et al., 2006; Mueller-Dieckmann et
al., 2006) and to hydrolyse O-acetyl-ADP-ribose (Ono et al., 2006).
ARH3 localizes to the mitochondrial matrix, where it can efﬁciently
degrade poly-ADP-ribose generated by mitochondrially targeted
PARP1 in living cells (Niere et al., 2008). PARG is encoded by a
single-copy gene in mammals, which is transcribed into different
splice variants that mediate differential subcellular localization to the
nucleus, cytosol and mitochondria (Meyer et al., 2007). PARG cleaves
ADP-ribosyl-ADP-ribose linkages but is not known to cleave ADP-
ribosyl-amino-acid linkages.
The only structurally characterized member of the ARH and
PARG protein families is human ARH3 (Kernstock et al., 2006;
Mueller-Dieckmann et al., 2006). The crystal structure of human
ARH3 revealed two Mg
2+ ions to be localized in the active-site
crevice. Since these are essential for the full activity of the protein,
which has been demonstrated for the related enzyme ARH1 (Moss et
al., 1985), they pinpoint the active site. Binding of ADP-ribose to
human ARH3 has been conﬁrmed by isothermal titration micro-
calorimetry experiments and the binding mode was evaluated by
docking studies (Mueller-Dieckmann et al., 2006). Site-directed
mutagenesis of amino-acid residues predicted to be involved in
binding ADP-ribose and/or the magnesium ions resulted in a severe
loss of enzymatic activity, supporting the suggested binding mode
(Mueller-Dieckmann et al., 2006).
Mouse ARH3 (ADPRHL2) consists of 370 amino acids and shares
17 and 16% amino-acid sequence identity with the mouse paralogues
ARH1 and ARH2, respectively, and 90% identity with the human
orthologue. Here, we present the structure of ARH3 from Mus
musculus reﬁned to a resolution of 1.8 A ˚ and a comparison with its
human orthologue and with other structurally related proteins.
2. Materials and methods
2.1. Cloning, expression and purification
A cDNA clone encompassing the coding region for mARH3 was
obtained from the IMAGE consortium (IMAGE Consortium Clone
ID 5293159; Lennon et al., 1996). The ARH coding region excluding a
putative N-mitochondrial targeting sequence (residues 2–23) was
ampliﬁed by PCR with appropriate primers (50-CGATGACCA-
TATGCGCTCCATCTCGCGCTTCCG-30 and 50-AAGCACTCGA-
GCGAGCTCTCCTGGAAGACTCGGT-30) and cloned into the
NdeI and XhoI sites of the prokaryotic expression plasmid pET26b
(Novagen). This cloning strategy resulted in the removal of the pelB
leader sequence from pET26b, the deletion of residues 2–23 of
mARH3 and a C-terminal extension of two amino acids encoded by
the XhoI recognition sequence (Leu-Glu) followed by a hexahisti-
dine tag. The correct cloning of the gene was veriﬁed by DNA
sequencing.
The expression plasmid pET26b-mARH3 was freshly transformed
into Escherichia coli BL21-CodonPlus(DE3)-RIL cells (Stratagene).
A single colony was picked for an overnight preculture, which took
place at 310 K in LB broth medium containing 50 mgm l
 1 kanamycin
and 30 mgm l
 1 chloramphenicol. 5–10 ml of this preculture was used
to inoculate a 1 l culture, which was grown at 310 K to an optical
density at 600 nm (OD600) of approximately 0.5. The temperature was
then reduced to 293 K and expression was induced by adding
isopropyl  -d-thiogalactopyranoside (IPTG) to a ﬁnal concentration
of 1 mM when an OD600 of about 0.7 was reached. After induction,
cells were grown for an additional 15 h and harvested. The cells were
then frozen at 253 K until further processing.
1 g of the cells was suspended in 4 ml lysis buffer [50 mM Tris pH
8.0, 150 mM NaCl, 3 mM  -mercaptoethanol ( -ME), 10 mM MgCl2
and 0.1%(v/v) Trition X-100]. After lysis by sonication, the cell debris
was removed by centrifugation at 20 000 rev min
 1 at 277 K for
30 min. The clear supernatant was passed onto an Ni–NTA Superﬂow
column (Qiagen) that had been equilibrated with lysis buffer. After
extensive washing (ten column volumes) with washing buffer (50 mM
Tris pH 8.0, 300 mM NaCl, 3 mM  -ME and 5 mM MgCl2), the
protein was eluted in a buffer containing 50 mM Tris pH 8.0, 300 mM
NaCl, 3 mM  -ME, 5 mM MgCl2 and 500 mM imidazole. The eluate
was concentrated to a volume of less than 1 ml and directly applied
onto a Sephacryl-S200 size-exclusion column (Amersham Phar-
macia). mARH3 eluted in a buffer containing 50 mM Tris pH 8.0,
150 mM NaCl and 2 mM DTT with a molecular weight of about
40 000 Da, corresponding to a monomer in solution. Protein-
containing fractions exhibiting a purity of higher than 95% were
pooled, concentrated and dialyzed extensively against 10 mM
HEPES pH 7.0 and 150 mM NaCl. Typical yields were around 15 mg
of pure protein per litre of culture.
2.2. Crystallization
Prior to crystallization, the protein concentration was adjusted to
5m gm l
 1. Initial screening for crystals was performed at the High-
Throughput Crystallization facility of the EMBL Outstation in
Hamburg (Mueller-Dieckmann, 2006). The sample was tested in ﬁve
commercial initial screens (Crystal Screens I and II, Index and SaltRx
from Hampton Research and Jena 1–8 from Jena Bioscience). In the
reﬁned crystallization conditions, crystals were grown at 295 K,
mixing protein and reservoir solution [100 mM MES pH 6.2 and
6%(w/v) PEG 4000] in a 1:1 ratio. Crystals appeared within one to
two weeks as long needles that were often badly grown together (up
to 1 mm in length and 150 mm in width; Fig. 2).
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Figure 1
The reversible ADP-ribosylation reaction. ARTs and PARPs catalyse the transfer
of an ADP-ribose moiety from NAD onto speciﬁc amino-acid residues or onto
ADP-ribose, respectively, thereby releasing nicotinamide. The reverse reaction is
catalysed by ARHs or PARGs through the hydrolysis of the  -glycosidic bond
between ADP-ribose and the side chain. X can be Arg, Asp, Glu, Asn, Cys,
diphthamide or ADP-ribose. For mono-ADP-ribosylation R and R0 are hydroxyl
groups, while for poly-ADP-ribosylation ADP-ribose can be attached to the R site
(elongation) or to the R0 site (branching).2.3. Structure determination and refinement
Prior to diffraction data collection, a crystal of mARH3 was
cryoprotected by soaking it in 20%(v/v) glycerol in reservoir solution
for 20 s and then ﬂash-cooled in a 100 K nitrogen stream. Diffraction
data were then collected to a diffraction limit of 1.8 A ˚ (Table 1) at
EMBL beamline X11 (DESY Hamburg, Germany) using a MAR
CCD (165 mm) detector. The data were indexed, integrated and
scaled using DENZO and SCALEPACK (Otwinowski & Minor,
1997). Intensities were converted to structure-factor amplitudes using
the program TRUNCATE (French & Wilson, 1978; Collaborative
Computational Project, Number 4, 1994). Initial phases were
obtained by molecular replacement with the program MOLREP
(Vagin & Teplyakov, 1997; Collaborative Computational Project,
Number 4, 1994) using the human orthologue (Mueller-Dieckmann et
al., 2006) as a search model (PDB code 2foz). After having correctly
oriented and placed both molecules in the asymmetric unit, the model
amino-acid sequence was modiﬁed to reﬂect the sequence of mouse
ARH3 using the program Coot (Emsley & Cowtan, 2004; Colla-
borative Computational Project, Number 4, 1994). Reﬁnement was
performed using the program REFMAC5( W i n net al., 2001; Colla-
borative Computational Project, Number 4, 1994). Reﬁnement
statistics are summarized in Table 2.
3. Results and discussion
3.1. Overall structure
The complete model consists of 674 amino acids in two protomers,
four Mg
2+ ions and 200 water molecules. Although the content of the
asymmetric unit of the crystal is two protomers, the most likely
biological unit is a monomer, as also evidenced by size-exclusion
chromatography, which indicates that the protein is monomeric in
solution. Both all- -helical protomers are composed of 19  -helices,
with two Mg
2+ ions that pinpoint the active-site crevice, and have
dimensions of approximately 53   50   62 A ˚ 3 (Fig. 3 and Fig. 4). The
ﬁrst 23 N-terminal amino-acid residues, i.e. the predicted mitochon-
drial targeting sequence, have been replaced by a Met residue during
protein structure communications
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Table 2
Reﬁnement statistics.
Reﬁnement
Resolution limits (A ˚ ) 30–1.80
No. of reﬂections
Working set 50111
Test set 975
Rcryst (%) 16.7
Rfree (%) 19.8
No. of atoms
Protein 5181
Ions 4
Waters 200
Stereochemistry
R.m.s. deviations
Bonds (A ˚ ) 0.016
Angles ( ) 1.47
Average B factors (A ˚ 2)
Protein 18.3
Ions 12.5
Waters 19.6
Ramachandran plot
Most favoured (%) 97.0
Allowed (%) 2.4
Figure 2
Crystal of mARH3. The bar in the upper right corner corresponds to 100 mm.
Table 1
Data-collection and processing statistics.
Data-collection wavelength 0.8126
Space group P21
Unit-cell parameters
a (A ˚ ) 53.88
b (A ˚ ) 60.10
c (A ˚ ) 91.78
  ( ) 90.09
Resolution limits (A ˚ ) 99–1.80 (1.83–1.80)
Mosaicity ( )1 . 0
Total no. of reﬂections 345718
No. of unique reﬂections 51153
Redundancy 6.8 (6.5)
hI/ (I)i 23.9 (2.5)
Completeness 93.8 (89.2)
Rmerge† (%) 7.7 (80.3)
Rr.i.m.‡ (%) 8.3 (87.0)
Rp.i.m.‡ (%) 3.1 (32.9)
Optical resolution (A ˚ ) 1.49
Overall B factor from Wilson plot (A ˚ 2) 24.8
† Rmerge(I)=
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ The redundancy-
independent merging R factor (Rr.i.m. =
P
hkl½N=ðN   1Þ 
1=2 P
i jIiðhklÞ h IðhklÞij= P
hkl
P
i IiðhklÞ) and the precision-indicating merging R factor {Rp.i.m. = P
hkl½1=ðN   1Þ 
1=2P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ} (Weiss, 2001) were calculated
using the program RMERGE (available from MSW upon request or from http://
www.embl-hamburg.de/~msweiss/projects/msw_qual.html).
Figure 3
Ribbon-plot representation of mARH3. The colouring scheme is from the
N-terminus (blue) to the C-terminus (red). It is identical to that chosen for the
human orthologue (Mueller-Dieckmann et al., 2006) for better comparison. The
two magnesium ions in the active-site crevice are shown as cyan spheres. The ill-
deﬁned loop between  -helices 2 (dark blue) and 3 (light blue) has not been drawn
in the representation.cloning. The loop regions from Asp45 to Thr54 in both protomers A
and B as well as the two C-terminal serine residues and the subse-
quent His6 tag are missing from the model owing to ill-deﬁned
electron density. The two protomers in the asymmetric unit exhibit an
average r.m.s. deviation of only 0.69 A ˚ for all 335 superimposed C
 
positions. A comparison of the B-factor distribution with the differ-
ence of C
  positions in both protomers shows that the regions exhi-
biting higher B factors generally also exhibit the highest C
 
discrepancies. The four internal loop regions are (i) the ‘missing’ loop
(residues 45–54), (ii) the loop region between  -helices 10 and 11
(residues 188–192), which is situated at the crystal contact between
the two protomers, (iii) the loop region between  -helices 12 and 13
(residues 218–224), which is also on the surface, and (iv) the loop
between  -helices 15 and 16 (residues 271–283), which like (ii) can be
found at the crystal contact of the two protomers.
3.2. Active site
The chain termini are situated close to each other on the same side
of the molecule. Two Mg
2+ ions are located at the opposite side of the
molecule within a cleft that spans nearly the entire width of the
molecule. These metal ions are separated from each other by 3.74 A ˚
and pinpoint the active site in which the ADP-ribose polymer is
hydrolysed. The four tightly bound ions (two per protomer) show an
average B factor of 12.5 A ˚ 2, which is lower than the average B factor
for the protein itself (18.3 A ˚ 2) and explains why Mg
2+ ions did not
have to be present during size-exclusion chromatography and crys-
tallization. Each of the Mg
2+ ions is nearly perfectly octahedrally
coordinated by three and ﬁve acidic residues (Glu and Asp),
respectively, one Thr residue and two water molecules. The corre-
sponding residues, distances and deviation from ideal geometry are
listed in Table 3. Whilethe distances to the coordinating atoms for the
ﬁrst Mg
2+ ion deviate on average just 4.5% from ideal distances, the
deviation from ideality is much higher for the second Mg
2+ ion
(16.9%).This is accompanied by a higher ﬂexibility for the second ion
(B factor of 12.9 A ˚ 2 compared with 8.2 A ˚ 2 for the ﬁrst ion). It is this
tempting to speculate that the ﬁrst Mg
2+ ion serves a structural role
while the second Mg
2+ ion contributes to enzymatic activity by acting
as an electron sink. This notion is corroborated by docking experi-
ments performed on human ARH3, in which the second Mg
2+ ion
coordinates the 20-hydroxyl group of the ribose carrying the scissile
glycosidic bond (Mueller-Dieckmann et al., 2006).
3.3. Comparison with human ADP-ribosylhydrolase 3
A superposition of the two protomers of ARH3 from mouse with
the structure of human ARH3 (PDB code 2foz) shows an r.m.s.
deviation of only 0.40 A ˚ for 336 superimposed C
  atoms for the ﬁrst
protomer and 0.52 A ˚ for 331 superimposed C
  atoms for the second
protein structure communications
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Figure 4
Ribbon-plot representation and protein solvent-accessible surface representation.
The colouring scheme for the protein chain is from the N-terminus (blue) to the C-
terminus (red). The solvent-accessible surface is coloured grey and the two Mg
2+
ions are shown as cyan spheres.
Table 3
Coordination of the two Mg
2+ ions.
Bridging atoms are highlighted in bold. Mean distances from structures in the PDB at
near-atomic resolution are 2.09 A ˚ for Mg
2+—OH2,2 . 1 0A ˚ for Mg
2+—O Thr, 2.08 A ˚ for
monodentate Mg
2+—
 OOC Asp/Glu and 2.5 A ˚ as the maximal accepted distance of
bidentate Mg
2+—
 OOC Asp/Glu (Harding, 2001, 2006). The two coordinating atoms of
the Mg-II ion that differ by more than 50% from the mean distance are indicated in
italics. Values for the deviation of the mean distance assuming a bidentate coordinating
nature are given in parentheses.
Coordinating atom Distance (A ˚ ) Deviation from mean distance (%)
Mg-I
Thr60 OG1 2.32 +10.5
Asp61 OD1 2.03  2.4
Asp62 OD2 1.93  7.2
Asp300 OD2 2.01  3.4 (19.6)
W20 2.10 +0.5
W61 2.02  3.3
Mg-II
Glu25 OE2 2.26 +8.7
Asp298 OD1 2.17 +4.3 (13.2)
Asp298 OD2 3.42 +64.4 (36.8)
Asp300 OD1 2.20 +5.8 (12.0)
Asp300 OD2 3.16 +51.2 (26.4)
Thr301 OG1 2.32 +10.5
W38 2.27 +8.6
W61 2.23 +6.7
Table 4
Amino-acid substitutions between mouse and human ARH3.
Conservative substitutions are marked with an asterisk after the amino-acid position.
Amino-acid
position
Amino acid in
mARH3
Amino acid
in hARH3 Comment
4* Ile Leu
22* Ala Ser 6.6 A ˚ from Mg
23* Val Phe
31 Ser Asp
33* Ala Thr
37 Ser Arg
40* GluA Gln Salt bridge to ArgB117 (sym)
52 Ala Glu
56* Thr Ala
66* Thr Ala Located in protein core
105* Ile Val
120* TyrB Phe Hydrogen bond to GluB81
189 Val Glu
197 Glu Lys
205* Glu Asp
217* Lys Arg
233* Val Ile Located in protein core
240 Asp Ala
241 Val Ser
243* SerA Thr Hydrogen bond to GluA245
SerB Thr Hydrogen bond to GluB246
275 His Asp
281* Thr Ala
317* Glu Asp
330* Phe Tyr
335* Val Ile
346 GluB Lys Hydrogen bond to HisB341protomer. Compared with the human ARH3 protein, there are a total
of 26 substituted amino-acid residues, of which 17 can be described as
conservative substitutions (Fig. 5). Table 4 lists all of the substitutions
between mouse and human ARH3. All but two substitutions are
located on the protein surface and do not alter the electrostatic
surface potential. The two substitutions which are not located on the
protein surface but in the protein core are Thr66 and Val233, which
are Ala and Ile in the human orthologue, respectively. Both substi-
tutions are far away from the active-site crevice. Thr66 is located on
 -helix 3 and its closest distance to the Mg
2+ ions is around 10 A ˚ .I t
forms a hydrogen bond to the carbonyl O atom of Asp62 through its
hydroxyl group (2.8 A ˚ ), which is in turn involved in the Mg
2+ co-
ordination. The substitution of Ala by Thr increases the number of
hydrogen bonds formed by the carbonyl O atom of Asp62 from three
to four.A comparison with the human protein shows that the position
of Asp62 is unaltered, suggesting that the substitution has no effect
on the activity of the protein. Val233, on the other hand, is located
around 19 A ˚ away from the active site on  -helix 12 at the hydro-
phobic interface with  -helix 14. The substitution of Ile by Val leaves
a hole at the position of the missing methyl group but presumably
does not have an effect either on the stability of the protein or on the
enzymatic activity. A comparison of the residues coordinating the two
protein structure communications
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Figure 5
Sequence alignment of ARHs. All three ARH families from M. musculus (mm) and Homo sapiens (hs) were aligned using the program ClustalW (Chenna et al., 2003); the
numbering of residues is according to the mARH3 sequence in the crystal structure (2qty), i.e. without the mitochondrial targeting sequence. Identical residues are shown in
red and similar residues are shown in blue. Residues that participate in the coordination of the two Mg
2+ ions are underlined. Sequence identities within the family from
M. musculus are 16.2% for mARH3 and mARH2, 17.4% for mARH3 and mARH1 and 42.1% for mARH1 and mARH2, while the sequence identity between mARH3 from
M. musculus and H. sapiens is 89.7%.Mg
2+ ions shows essentially no difference (the r.m.s. deviation is
0.11 A ˚ for 55 atoms), which suggests that the active site is not altered
between the two proteins. Likewise, those 14 residues that were
identiﬁed in human ARH3 as being likely to participate in the
binding of ADP-ribose (Glu25, Asp61, Gly103, Val104, Thr106,
Asn126, Phe127, Ser132, Tyr133, Asn135, His166, Glu259, Asp298
and Thr301) have an r.m.s. deviation to the mouse orthologue of only
0.55 A ˚ (for 115 atoms), implying that the binding mode is essentially
the same in those two proteins.
3.4. Comparison of the structural fold of mARH3 to prokaryotic
homologues
A protein structure comparison of mARH3 with proteins depos-
ited in the PDB using DALI (Holm & Sander, 1996) and SSM
(Krissinel & Henrick, 2004) gave the structure of the human ortho-
logue with the highest Z score for both search algorithms (see x3.3
and Table 5). In addition, two prokaryotic proteins (PDB codes 1t5j
from the archaeon Methanococcus janaschii and 2cwc from the
Gram-negative eubacterium Thermus thermophilus), as well as two
metal complexes of 2cwc (2yzv and 2yzw), were identiﬁed using the
program SSM with Z scores of 9.4, 8.5 and 8.4, respectively. Like
mARH3, they are all- -helical proteins and show a high degree of
structural similarity (82% and 79% of all amino-acid residues can be
superimposed with an r.m.s. deviation of 1.4 A ˚ for 246 C
  positions
for 1t5j and 240 C
  positions for 2cwc; Table 5). The proposed active-
site crevice shows a high degree of agreement of the positions of the
 -helices and loop structures that form this crevice. However, there
are also two notable differences in terms of the apparent accessibility
to this crevice. An additional  -helix (helix 2) that is present in mouse
ARH3 (as well as the human protein) but not in the prokaryotic
proteins seems to block access to the active site from this side. The
other difference concerns the ‘missing loop’ region (Asp45–Thr54) in
mouse ARH3 (and its human orthologue). The corresponding region
in 1t5j and 2cwc folds back and forms a kind of lid that blocks access
from this side of the active site. To gain full accessibility to the two
Mg
2+ ions, this lid would need to move away. In the case of 1t5j at
least, there is one residue within this lid (Tyr49) that participates in a
hydrogen-bonding network together with other Mg
2+-coordinating
residues.
The data for 2cwc and its two metal-ion-containing analogues 2yzv
and 2yzw were all collected by the RIKEN structural genomics/
proteomics initiative at SPring-8 in Japan at a wavelength of 1.0 A ˚ to
rather high resolutions of 1.65 A ˚ (2cwc), 1.60 A ˚ (2yzv) and 1.70 A ˚
(2yzw). The structures of 2yzv, which contains two Mg
2+ ions, and of
2yzw, which contains two Gd
3+ ions, superimpose very well on each
other with an r.m.s. deviation of 0.16 A ˚ for 283 superimposed C
 
atoms, as well as with 2cwc with an r.m.s. deviations of 0.24 A ˚ for 284
superimposed C
  atoms for 2yzv and 0.26 A ˚ for 282 superimposed C
 
atoms for 2yzw. The two Mg
2+ ions within the 2yzv structure are 3.5 A ˚
apart from each other. The ﬁrst Mg
2+ ion, with a B factor of 18 A ˚ 2,i s
coordinated by one Thr and two Asp residues (both coordinating
bidentally), while the second ion has a higher B factor of 30 A ˚ 2 and is
coordinated by one Thr and three Asp residues (one coordinating
bidentally). Both ions are not octahedrally coordinated because there
are no coordinating water molecules. A comparison with the 2cwc
structure shows little structural difference for the three coordinating
residues for the ﬁrst Mg
2+ ion, while for the second Mg
2+ ion two of
the three coordinating Asp residues have shifted by 3.4 and 6.3 A ˚ .
Compared with mouse ARH3, there is hardly any difference in the
coordination of the ﬁrst Mg
2+ ion, although Glu25 in the ARH3
structure is within coordination distance of this ion. The second Mg
2+
ion also shows good agreement compared with ARH3, with the
exception that one Asp residue has moved by 1.9 A ˚ .
The situation is similar for 2yzw, which contains two Gd
3+ ions
3.76 A ˚ apart from each other with comparable B factors of 13 and
16 A ˚ 2. Although the maximal resolution of this structure is somewhat
lower than that of 2yzv, both ions are roughly octahedrally coordi-
nated. The ﬁrst Gd
3+ ion is coordinated by two water molecules (of
which one is a bridging water molecule between the two metal ions),
one Thr, one Glu and two Asp residues (one Asp residue coordinates
to both metal ions) and the second Gd
3+ ion is coordinated by one
Thr and three Asp residues as well as two water molecules. A
comparison with the structure of 2cwc shows a large movement of the
Glu residue (by 1.8 A ˚ ) for the ﬁrst Gd
3+ ion and also a large move-
ment of two of the three coordinating Asp residues. Compared with
the mouse ARH3 structure, there is hardly any movement within the
coordinating residues of both metal ions apart from a 0.9 A ˚ move-
ment of the coordinating Glu residue.
Using the search algorithm from the program DALI a (weak)
structural similarity (Z scores of 4.2 and 2.4, respectively) was
detected to two bacterial enzymes (PDB codes 1mro and 2ooe), one
of which is involved in bacterial methanogenesis and the other in
polyadenylation of mRNA precursors. Given the fact that only 68 out
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Table 5
Structural comparison of mARH3 using the search algorithms from DALI (Holm & Sander, 1996) and SSM (Krissinel & Henrick, 2004).
Only results with a Z score higher than 2 are listed. The superposition of mARH3 with the corresponding protein was performed with the brute-force method implemented in the
program LSQMAN (Novotny et al., 2004), from which the number of superimposed amino-acid residues, r.m.s. deviation and r.m.s. B factor values were taken.
Protein name Organism
PDB
code
Annotated
function
Space
group
Resolution
(A ˚ )
No. of
amino-acid
residues
No. of
superimposed
C
  positions
Z
score
R.m.s.
deviation
(A ˚ )
R.m.s.
B factor
(A ˚ 2) Reference†
ADP-ribosylhydrolase 3 H. sapiens 2g4k De-ADP-ribosylation P212121 1.82 336 336 63.3‡,
15.7§
0.47 14.5 a
ADP-ribosylhydrolase 3 H. sapiens 2fp0 De-ADP-ribosylation P21 2.05 335 335 15.9§ 0.58 30.0 b
ADP-ribosylhydrolase 3 H. sapiens 2foz De-ADP-ribosylation P212121 1.60 336 336 15.9§ 0.40 6.2 b
Ribosylglycohydrolase MJ1187 Methanococcus jannaschii 1t5j Unknown P43212 2.70 301 246 9.4§ 1.36 34.1 c
ADP-ribosylglycohydrolase T. thermophilus HB8 2cwc De-ADP-ribosylation P212121 1.65 303 240 8.5§ 1.44 6.5 d
ADP-ribosylglycohydrolase T. thermophilus HB8 2yzw De-ADP-ribosylation P212121 1.70 303 241 8.5§ 1.30 6.8 e
ADP-ribosylglycohydrolase T. thermophilus HB8 2yzv De-ADP-ribosylation P212121 1.60 303 241 8.4§ 1.42 6.4 e
Methyl-coenzyme M reductase Methanobacterium
thermoautotrophicum
1mro Methanogenesis P21 1.16 548 69 4.2‡ 2.14 4.4 f
Hat domain of murine CstF-77 Mus musculus 2ooe Polyadenylation of
mRNA precursors
H32 3.00 400 54 2.5‡ 2.22 40.3 g
†( a) Mueller-Dieckmann et al. (2007); (b) Mueller-Dieckmann et al. (2006); (c) deposited in the PDB 11 May 2004; (d) deposited in the PDB 18 June 2005; (e) deposited in the PDB 6
November 2007; (f) Ermler et al. (1997); (g) Bai et al. (2007). ‡ Results from DALI. § Results from SSM.of 548 amino-acid residues can be superimposed with an r.m.s.
deviation of 2.06 A ˚ for 1mro (Ermler et al., 1997) and 54 out of 400
amino-acid residues with an r.m.s. deviation of 2.22 A ˚ for 2ooe (Bai et
al., 2007), it is clear that these proteins do not share a common fold
with mARH3.
4. Summary and conclusion
We have determined the three-dimensional crystal structure of
murine ADP-ribosylhydrolase 3 to 1.8 A ˚ resolution. The structure
constitutes a compact all- -helical protein with two Mg
2+ ions that
pinpoint the active-site crevice. A comparison with the recently
published structure of the human orthologue (Mueller-Dieckmann et
al., 2006) shows a high degree of structural consistency; similar
observations were made using the three-dimensional structures of
four prokaryotic proteins deposited in the PDB.
Parts of the work described in this study represent partial fulﬁl-
ment of the requirements for the doctoral thesis of SK at the
University of Hamburg. This work was supported by grants from the
Deutsche Forschungsgemeinschaft (to FK-N and MSW) and the
Studienstiftung des deutschen Volkes (to SK).
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